Celecoxib and sulindac sulfide elicit anticancer effects on PIK3CA-mutated head and neck cancer cells through endoplasmic reticulum stress, reactive oxygen species, and mitochondrial dysfunction
Article in Biochemical Pharmacology (April 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Biochemical Pharmacology (April 2024)
Article in The European Research Journal (March 2024)
Article in Heliyon (September 2023)